Twist Bioscience ( (TWST) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Twist Bioscience shares are under pressure despite management showcasing its synthetic biology platform and growth plans at the William Blair 46th Annual Growth Stock Conference. Investors are reassessing the stock after a recent quarterly earnings miss, even as the company highlights new products and strategic initiatives.
Analysts had previously raised their outlook on Twist Bioscience, encouraged by strong revenue growth and favorable revisions to long-term targets. Recent launches, including its Complex Genes portfolio and lower-cost RNA sequencing solutions, had improved sentiment, but the latest results are prompting a fresh look at those optimistic price targets.
More about Twist Bioscience
YTD Price Performance: 120.81%
Average Trading Volume: 1,381,289
Technical Sentiment Signal: Buy
Current Market Cap: $4.36B
For further insights into TWST stock on
TipRanks’ Stock Analysis page.
See more of today’s
top stock gainers and losers.